Kenta Biotech AG
  • Home
  • Shop
  • Events
  • Courses
  • Services
  • Pricing
  • Company
    • Blog
    • Success Stories
    • About Us
  • Appointment
  • Contact us
  • 0
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
Kenta Biotech AG
  • 0
    • Home
    • Shop
    • Events
    • Courses
    • Services
    • Pricing
    • Company
      • Blog
      • Success Stories
      • About Us
    • Appointment
    • Contact us
  • +1 (718) 513-2983
  • Sign in
  • Contact Us
  1. Products
  2. Assay test kits
Public Pricelist
Public Pricelist
Sort By: Featured
Featured Newest Arrivals Name (A-Z) Price - Low to High Price - High to Low

Assay test kits

[0197-MET-5012] Lactate Assay Tests (Colorimetric) 100 Assays
Lactate Assay Tests (Colorimetric) 100 Assays
600.00 € 600.0 EUR
[0544-MBS733861-96T] LH elisa Test :: Fish Luteinizing Hormone (LH) ELISA Test, 96 tests
LH elisa Test :: Fish Luteinizing Hormone (LH) ELISA Test, 96 tests
980.00 € 980.0 EUR
[0914-844101] LEGEND MAX Human α-Synuclein ELISA Test - 96 Tests
LEGEND MAX Human α-Synuclein ELISA Test - 96 Tests
739.20 € 739.2 EUR
[0749-KTA1030-96T] LDH Cytotoxicity Assay Test, 96 tests
LDH Cytotoxicity Assay Test, 96 tests
179.00 € 179.0 EUR
[0749-KTA1030-480T] LDH Cytotoxicity Assay Test, 480 tests
LDH Cytotoxicity Assay Test, 480 tests
275.00 € 275.0 EUR
[0513-DEIA048] Kanamycin ELISA Test, 96 tests
Kanamycin ELISA Test, 96 tests
1,645.00 € 1645.0 EUR
[0879-KBBA05] KRISHZYME Hyaluronidase Enzymatic Assay Test 200 tests / 1 Test
KRISHZYME Hyaluronidase Enzymatic Assay Test 200 tests / 1 Test
988.00 € 988.0 EUR
KRIBIOLISA Adalimumab ELISA,96 tests
KRIBIOLISA Adalimumab ELISA,96 tests
809.00 € 809.0 EUR
[0270-ED7056-50TESTS] KOMBITEST CD45 FITC / CD14 PE - 50 tests
KOMBITEST CD45 FITC / CD14 PE - 50 tests
378.00 € 378.0 EUR
[0270-ED7053] KOMBITEST CD3 FITC / CD19 PE - 50 tests
KOMBITEST CD3 FITC / CD19 PE - 50 tests
378.00 € 378.0 EUR
[0270-ED7054-50TESTS] KOMBITEST CD3 FITC / CD16 + CD56 PE - 50 tests
KOMBITEST CD3 FITC / CD16 + CD56 PE - 50 tests
378.00 € 378.0 EUR
[0544-MBS4500594-96T] KLb rtu elisa Test :: Human Klotho Beta (KLb) RTU ELISA Test, 96 tests
KLb rtu elisa Test :: Human Klotho Beta (KLb) RTU ELISA Test, 96 tests
872.00 € 872.0 EUR
[MBS1600685-96] KLF3 elisa Test :: Rat Krueppel-like Factor 3 (KLF3) ELISA Test - 96 Tests
KLF3 elisa Test :: Rat Krueppel-like Factor 3 (KLF3) ELISA Test - 96 Tests
661.00 € 661.0 EUR
[0544-MBS1600685] KLF3 elisa Test :: Rat Krueppel-like Factor 3 (KLF3) ELISA Test - 48 Tests
KLF3 elisa Test :: Rat Krueppel-like Factor 3 (KLF3) ELISA Test - 48 Tests
429.00 € 429.0 EUR
[0544-MBS2601395-96T] KL-6 elisa Test :: Human Krebs Von den Lungen-6 (KL-6) ELISA Test, 96 tests
KL-6 elisa Test :: Human Krebs Von den Lungen-6 (KL-6) ELISA Test, 96 tests
620.00 € 620.0 EUR
[0852-IOV87952] Invbio Saliva Test - 20 Tests/Test
Invbio Saliva Test - 20 Tests/Test
1.00 € 1.0 EUR
[0852-INV-1111] Invbio AFP test strip 100 Tests/Test 3.0mm (single pouch)  100pouches/box
Invbio AFP test strip 100 Tests/Test 3.0mm (single pouch) 100pouches/box
133.00 € 133.0 EUR
[0246-9144] Intracellular Total ROS Activity Assay Test - 100 Tests
Intracellular Total ROS Activity Assay Test - 100 Tests
634.00 € 634.0 EUR
[0501-Kit-2077] Intestinal Permeability Assay Test, 100 tests
Intestinal Permeability Assay Test, 100 tests
2,600.00 € 2600.0 EUR
[0563-R0187C] Influenza A/B Ag Rapid Test CE - 20 tests/Test
Influenza A/B Ag Rapid Test CE - 20 tests/Test
427.70 € 427.7 EUR
  • 18
  • 19
  • 20
  • 21
  • 22

Clear Filters



Respiratory syncytial virus (RSV) infections are the most common cause of hospitalization in early childhood, accounting for 57 000 to 120 000 hospitalizations each year in the United States. RSV is causing annual epidemics of bronchiolitis and pneumonia worldwide. In most cases the infection with RSV heals without sequelae, yet RSV infection can cause lung function deterioration and in some circumstances, years of recurrent wheezing or asthma may ensue. Overall RSV accounts for an estimated2% of the hospitalization rate among infants less than 1 year of age. This rate increases 4–5-fold among high-risk patients such as premature infants and those with chronic lung disease or complicated congenital heart disease.


Currently there is only one possibility to prevent infections of at-risk patients with RSV, namely immuno-prophylaxis with palivizumab/Synagis, marketed by MedImmune. However, the response to palivizumab is variable among individuals, and sometimes palivizumab fails to prevent RSV infections effectively.


Due to the lack of better antibodies, lack of effective anti-viral treatment and lack of an effective preventive vaccine for RSV, there is a substantial medical need for more efficacious prophylactic immunizations, e.g. by antibody.


Kenta Biotech had developed a fully human monoclonal antibody (KBRV201) derived from B-cells of a human donor. KBRV201 is of the human IgG1 isotype with specificity and very high affinity for the F-protein of human respiratory syncytial virus (hRSV). KBRV201 has been tested for recognition and neutralization of hRSV strains -A, -B and –Long, and KBRV201 could neutralize in vitro all strains tested with higher efficacy than other anti-F-protein mAb.




KBRV201 successfully recognizes 22 clinical isolates from children infected with RSV, including one isolate with a mutated F-protein. Overall KBRV201 has demonstrated superiority in every experiment performed, and KBRV201 is currently undergoing extensive testing in animal models.

14009 NW Harbor Ln, Portland, OR 97229, USA.


Follow us
Copyright © 2025 Kenta Biotech AG
English (UK) English (US)